Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.12.05044523560777.9166
Domestic EquitiesCipla Ltd.7.89903374056509.9211
Domestic EquitiesDr. Reddy's Laboratories Ltd.7.82483973068505.1359
Domestic EquitiesDivi's Laboratories Ltd.7.0999716988458.3346
Domestic EquitiesMankind Pharma Ltd.6.43831892240415.6305
Domestic EquitiesLupin Ltd.5.78271769639373.3053
Domestic EquitiesAurobindo Pharma Ltd.5.19262833588335.2135
Domestic EquitiesAlkem Laboratories Ltd.3.6619429308236.3985
Domestic EquitiesCohance Lifesciences Ltd.3.00683672095194.1069
Domestic EquitiesSyngene International Ltd.2.98112956118192.4433
Domestic EquitiesZydus Lifesciences Ltd.2.49461761233161.0383
Domestic EquitiesAlivus Life Sciences Ltd.2.23861576606144.5117
Domestic EquitiesThyrocare Technologies Ltd.1.93622804472124.9953
Domestic EquitiesAlembic Pharmaceuticals Ltd.1.89191443386122.1321
Domestic EquitiesAkums Drugs and Pharmaceuticals Ltd.1.71372439962110.6279
Domestic EquitiesMedi Assist Healthcare Services Ltd1.71362407739110.6236
Domestic EquitiesJ.B.Chemicals & Pharmaceuticals Ltd.1.6313578725105.3106
Domestic EquitiesGland Pharma Ltd.1.533657490898.9992
Domestic EquitiesEntero Healthcare Solutions1.529096145598.7030
Domestic EquitiesPfizer Ltd.1.398218097090.2624
Domestic EquitiesMedplus Health Services Ltd1.3394107108486.4686
Domestic EquitiesBlue Jet Healthcare Ltd.1.3162160254384.9668
Domestic EquitiesMetropolis Healthcare Ltd.1.309243815584.5157
Domestic EquitiesGlenmark Pharmaceuticals Ltd.1.194337882277.0979
Domestic EquitiesHikal Ltd.1.1301321624172.9540
Domestic EquitiesAarti Drugs Ltd.1.0980172192470.8830
Domestic EquitiesFine Organic Industries Ltd.1.086517039970.1396
Domestic EquitiesAnthem Biosciences Ltd1.0623105263668.5792
Domestic EquitiesWindlas Biotech Ltd.1.056385765168.1875
Domestic EquitiesShilpa Medicare Ltd.0.9583192629861.8631
Domestic EquitiesSanofi Consumer Healthcare India Ltd0.861512304955.6169
Domestic EquitiesLaxmi Dental Ltd.0.8391198828454.1708
Domestic EquitiesSenores Pharmaceuticals Ltd0.816264088352.6934
Domestic EquitiesFDC Ltd.0.7850119768950.6742
Domestic EquitiesAstrazeneca Pharma India Ltd.0.76955502149.6785
Domestic EquitiesRubicon Research Ltd0.761072168049.1284
Domestic EquitiesProcter & Gamble Health Ltd.0.63147147140.7599
Domestic EquitiesSun Pharma Advanced Research Co. Ltd0.4443213320628.6810
Domestic EquitiesNephrocare Health Services Ltd0.394654348825.4733
Total 97.8715 6318.1421
Cash & Cash Equivalents and Net AssetsTREPS2.0897 134.9021
Cash & Cash Equivalents and Net AssetsCash Margin - Derivatives0.1302 8.4052
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.0914 -5.9016
Total 2.1285 137.4057
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.